InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Singh Shawn, Chairman & CEO. Insider active across 1 companies, notably VistaGen Therapeutics, Inc.. In total, 5 filings have been published. The latest transaction was filed on 12 May 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations5 total
€96,343100,000 shares@ €0.96340.39% mcap78.1% of flow
Common Stock
SEC:0001415889-22-004988:0·
€5,3033,623 shares@ €1.46360.021% mcap39.2% of flow
Common Stock
SEC:0001415889-22-000034·
€5,3033,623 shares@ €1.46360.021% mcap4.3% of flow
Common Stock
SEC:0001415889-22-000034:0·
€8,2085,000 shares@ €1.64170.033% mcap60.8% of flow
Common Stock
SEC:0001415889-21-003387·
€8,2085,000 shares@ €1.64170.033% mcap6.7% of flow
Common Stock
SEC:0001415889-21-003387:0·
5 of 5 declarations
About Singh Shawn
Shawn Singh is the Chief Executive Officer of VistaGen Therapeutics, Inc. He is responsible for the strategic and operational leadership of the company. Singh plays a key role in innovation and growth, guiding the organization towards its objectives. His leadership is essential for ensuring the success and sustainability of the company.
